Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of NovaSure in the Presence of Essure Following the Essure Confirmation Test (ECT) Post-Approval Study

NCT01934244 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.

NCT NCT01934244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01934244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of NovaSure in the Presence of Essure Following the Essure Confirmation Test (ECT) Post-Approval Study
Lead sponsor
Hologic, Inc.
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2013
Completion date
January 31, 2019
Enrollment
318 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

menorrhagia